These results support the existence of a novel key signaling axis, RASAL2-AS1-METTL14-LIS1, which plays a regulatory role in m6A methylation modification levels and RNA stability during the development of HNSCC. This evidence concerns the gene RASAL2 and head and neck squamous cell carcinoma.